FUTURA MEDICAL - Key Persons

Job Titles:

• Independent Non - Executive Director
• Senior Independent Non - Executive Director

Andrew Unitt joined the Board on 1 January 2022 and brings strong financial experience having spent eleven years at Boots plc, where he was Finance Director for four years of Boots Healthcare International, its over the counter medicines business. Andrew Unitt is an Independent Non-Executive Director and is Chair of the Audit Committee, Nominations Committee and Remuneration Committee.

Job Titles:

• Chief Operating Officer
• Company Secretary
• Finance Director

Angela joined the Group in 2018. She leads the Group's finance, HR and IT functions, inputs into commercial and financial strategy, ensures its compliance procedures and is a principal contact for shareholder and investor relations matters. She is also an Independent Non-Executive Director and Chair of the Audit Committee at AIM-listed Aptamer plc.

Job Titles:

• Chief Executive
• Group 's Chief Executive

James Barder is the Group's Chief Executive. He assists the Remuneration Committee and the Nominations Committee (but is not a member of and does not vote on either). He has overall responsibility for all activities of the Group, is a principal contact for shareholder and investor relations and leads commercial negotiations. He is also a Non-Executive Director of Caisson IO Group Limited and a Director of the Mary How Trust for Cancer Prevention.

Job Titles:

• Chairman
• Non - Executive Chairman

Jeff Needham is Chairman of Futura Medical plc and is a member of the Remuneration Committee. He is also a member of the Nominations Committee. Jeff is currently on the Board of McKee Foods Corp.

Job Titles:

• Executive Director and Head of R & D

Ken James is the Head of R&D. He oversees the development, regulatory and manufacturing strategies for the Group's existing pipeline and the evaluation of early stage pipeline opportunities. He is also an Executive Director.

Job Titles:

• Independent Non - Executive Director

Roy brings a wealth of commercial experience in medical devices companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. He has held leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualisation, until its acquisition by Olympus Corporation in 2008 for $1.9 billion. He is currently Non-Executive Chair at LungLife AI plc, Foster and Freeman (the trading name of the Galton group of companies) and Rair Health Ltd and was until recently, Non-Executive Chair at Medica Group plc until its acquisition by IK Partners for £269 million earlier this year. On 7 December it was announced that Roy will become a Non-Executive Director and Chair Designate of Inspiration Healthcare Group plc with effect from 25 January 2024.

Job Titles:

• Profitability in Sight As Partner Preps for US Launch

Trinity Delta Futura Medical Eroxon continues to build, further new launches expected